Table 3 Appropriateness of medications as defined by PEACE consensus panel
Always appropriate | ||
Antidiarrheals | Antiepileptic drugs | Expectorants |
Laxatives | Anxiolytics | Lubricating eye drops |
Antiemetics | Narcotic analgesics | Pressure ulcer products |
Inhaled bronchodilators | Nonnarcotic analgesics | Lidoderm |
Sometimes appropriate | ||
Proton pump inhibitors | Antidepressants | Insulin |
Histamine-2 receptor blockers | Tricyclic antidepressants | Antihistamines |
Beta-blockers | Antibacterials | Decongestants |
Calcium channel blockers | Antivirals | Electrolytes |
Diuretics | Antiparasitic agents | Nutritional supplements |
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers | Antifungal creams | Antiglaucoma drops |
Nitroglycerin | Oral hypoglycaemics | Anti-inflammatory eye drops |
Mucolytics | Thyroid hormones | Capsaicin |
Inhaled corticosteroids | Antithyroid medications | Allopurinol |
Antipsychotics | Corticosteroids | Colchicine |
Rarely appropriate | ||
Alpha blockers | Antiandrogens | Appetite stimulants |
Digoxin | Bisphosphonates | Bladder relaxants |
Clonidine | Mineralocorticoids | Tamsulosin |
Antiarrhythmics | Heparin and low molecular-weight heparins | Antispasmodics |
Hydralazine | Warfarin | |
Never appropriate | ||
Lipid-lowering medications | Memantine | Cytotoxic chemotherapy |
Antiplatelet agents, excluding aspirin | Antiestrogens | Hormone antagonists |
Leukotriene receptor antagonists | Sex hormones | Immunomodulators |
Acetylcholinesterase inhibitors | ||
No consensus | ||
Aspirin | Meclizine | Bladder stimulants |
Sedatives and hypnotics | Vitamins | Iron |
Central nervous system stimulants | Mineral supplements | Finasteride |
Muscle relaxants | Calcitonin | Red blood cell colony stimulating factors |